PHENOGERIA: Impact of Age and Geriatric Co-morbidities on Lymphocyte Phenotype in Patients 70 Years of Age and Older
Study Details
Study Description
Brief Summary
An individual's immune profile changes with age, and can sometimes be involved in the development of certain diseases such as infections or cancers, in a process called immunosenescence. Some data tend to show that there is a link between this immune profile and geriatric fragility (autonomy, difficulties with walking, memory, undernutrition, co-morbidities, depression). The aim of this study is to describe this profile, or immune phenotype, and to see if there is a link with the different aspects of geriatric assessment in patients without cancer or infection. In addition, these data will serve as a basis for comparison with the same analyses performed on breast cancer patients at the Centre Georges François Leclerc.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Seniors 70 years of age and over, inpatients or outpatients |
Biological: Blood samples
during the routine blood test, collection of additional blood samples:
1 x 5 mL heparinized tube for plasma collection and storage
1 heparinized 5 mL tube for immunophenotyping
4 x 10 mL EDTA tubes for white blood cell (WBC) collection and cryopreservation
Other: Data collection
clinical examination data
test results to measure the degree of geriatric fatigability
Frailty screening questionnaire for neoplasia patients (G8 score)
|
Outcome Measures
Primary Outcome Measures
- percentage of immune cells in peripheral blood [At inclusion]
technique used: flow cytometry
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Person who has not opposed to inclusion in the study
-
Male or female aged 70 and over admitted to the Champmaillot Geriatric Center on an inpatient or outpatient basis.
Exclusion Criteria:
-
Person not affiliated to national health insurance system
-
Person subject to a measure of legal safeguard (curatorship, etc)
-
Person with an acute infection
-
Person with suspected cancer or active cancer
-
Long-term immunosuppressive or corticosteroid therapy
-
HIV and/or HBV and/or HCV positive serology
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CHU Dijon Bourgogne | Dijon | France | 21000 |
Sponsors and Collaborators
- Centre Hospitalier Universitaire Dijon
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- BARBEN 2020